Benzimidazole-proline derivatives
US-11040966-B2 · Jun 22, 2021 · US
This page is not indexed by search engines while we improve data quality.
Gude Markus patents
Gude Markus is listed as an inventor on 22 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Gude Markus |
| Total patents | 22 |
| First publication | Apr 7, 2015 |
| Latest publication | Jun 22, 2021 |
Notable patents
Publications ranked by popularity score, then publication date.
Benzimidazole-proline derivatives
US-2019263797-A1 · Aug 29, 2019 · US
Benzimidazole-proline derivatives
US-10329287-B2 · Jun 25, 2019 · US
Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
US-10023560-B2 · Jul 17, 2018 · US
Use of benzimidazole-proline derivatives
US-9914721-B2 · Mar 13, 2018 · US
Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists
US-9914720-B2 · Mar 13, 2018 · US
Crystalline salt form of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
US-2018002317-A1 · Jan 4, 2018 · US
Benzimidazole-proline derivatives
US-2017305897-A1 · Oct 26, 2017 · US
Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
US-9790208-B2 · Oct 17, 2017 · US
Benzimidazole-proline derivatives
US-9732075-B2 · Aug 15, 2017 · US
Recent patents
Latest publications not already listed above.
Use of benzimidazole-proline derivatives
US-2017001985-A1 · Jan 5, 2017 · US
Crystalline form of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1 -yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists
US-2016368901-A1 · Dec 22, 2016 · US
Crystalline salt form of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
US-2016355506-A1 · Dec 8, 2016 · US
Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives
US-9493446-B2 · Nov 15, 2016 · US
1-[m-carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide derivatives
US-9428456-B2 · Aug 30, 2016 · US
Pyrazole and imidazole derivatives useful as orexin antagonists
US-9303023-B2 · Apr 5, 2016 · US
Proline sulfonamide derivatives as orexin receptor antagonists
US-9211279-B2 · Dec 15, 2015 · US
1-[m-Carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide Derivatives
US-2015336893-A1 · Nov 26, 2015 · US
Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives
US-2015252032-A1 · Sep 10, 2015 · US
Proline sulfonamide derivatives as orexin receptor antagonists
US-2015246021-A1 · Sep 3, 2015 · US
Benzimidazole-proline derivatives
US-2015166527-A1 · Jun 18, 2015 · US
Proline sulfonamide derivatives as orexin receptor antagonists
US-9000029-B2 · Apr 7, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Actelion Pharmaceuticals Ltd | 14 |
| Idorsia Pharmaceuticals Ltd | 9 |
| Boss Christoph | 2 |
| Brotschi Christine | 2 |
| Gude Markus | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P25/00 | 20 |
| A61P25/28 | 17 |
| C07D403/14 | 16 |
| A61P25/22 | 15 |
| A61P25/20 | 15 |